Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has acquired Proof Diagnostics, an innovative life sciences tools, diagnostics and computational discovery company which uncovered genome engineering tools for both therapeutic and diagnostics applications while developing a smart, portable system for the detection of infectious and other diseases.   This news follows the recent announcement that Ginkgo acquired key assets of Reverie Labs. About the Proof A...